Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
478
mi
from
Memphis, TN
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
478
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
478
mi
from
Memphis, TN
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
478
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
340
mi
from
Dallas, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
340
mi
from
Dallas, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
348
mi
from
Fort Worth, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
348
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
777
mi
from
Salt Lake City, UT
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
1113
mi
from
Richmond, VA
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
GSK Investigational Site
632
mi
from
Milwaukee, WI
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
632
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
Therafirst Medical Centers
1305
mi
from
Fort Lauderdale, FL
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
Therafirst Medical Centers
1305
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
American Red Cross
782
mi
from
Douglasville, GA
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
American Red Cross
782
mi
from
Douglasville, GA
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
Evelyn Jordan Center
1148
mi
from
Baltimore, MD
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
Evelyn Jordan Center
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
Man Alive, Inc.
1149
mi
from
Baltimore, MD
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
Man Alive, Inc.
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
Reach (Ibr)
1148
mi
from
Baltimore, MD
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
Reach (Ibr)
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
University of Maryland School of Medicine
1148
mi
from
Baltimore, MD
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
University of Maryland School of Medicine
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated:  9/4/2015
Bellevue Hospital
1288
mi
from
New York, NY
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing
Status: Enrolling
Updated: 9/4/2015
Bellevue Hospital
1288
mi
from
New York, NY
Click here to add this to my saved trials
Clipping Versus No Hair Removal and the Risk of Surgical Site Infections
Clipping vs. No Hair Removal and the Risk of Surgical Site Infection: A Randomized, Assessor Blinded Non-inferiority Clinical Trial Among Patients Undergoing General Surgical Procedures at a Community Hospital
Status: Enrolling
Updated:  9/4/2015
Gundersen Lutheran Health System
541
mi
from
La Crosse, WI
Clipping Versus No Hair Removal and the Risk of Surgical Site Infections
Clipping vs. No Hair Removal and the Risk of Surgical Site Infection: A Randomized, Assessor Blinded Non-inferiority Clinical Trial Among Patients Undergoing General Surgical Procedures at a Community Hospital
Status: Enrolling
Updated: 9/4/2015
Gundersen Lutheran Health System
541
mi
from
La Crosse, WI
Click here to add this to my saved trials
Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways
Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways
Status: Enrolling
Updated:  9/9/2015
The Feinstein Institute for Medical Research
1303
mi
from
Manhasset, NY
Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways
Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways
Status: Enrolling
Updated: 9/9/2015
The Feinstein Institute for Medical Research
1303
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Universal Biopharma Research Institute
1187
mi
from
Dinuba, CA
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Universal Biopharma Research Institute
1187
mi
from
Dinuba, CA
Click here to add this to my saved trials
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Axis Clinical Trials
1173
mi
from
Los Angeles, CA
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Axis Clinical Trials
1173
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Universal Biopharma Reserach INC
1187
mi
from
Dinuba, CA
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Universal Biopharma Reserach INC
1187
mi
from
Dinuba, CA
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
LSRN Reserach
1280
mi
from
West Palm Beach, FL
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
LSRN Reserach
1280
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Axis Clinical Trials
1173
mi
from
Los Angeles, CA
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Axis Clinical Trials
1173
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Impact Clinical Trials
961
mi
from
Las Vegas, NV
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Impact Clinical Trials
961
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Haber Dermatology
903
mi
from
Beachwood, OH
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Haber Dermatology
903
mi
from
Beachwood, OH
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
McKenzie Medical Center
525
mi
from
McKenzie, TN
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
McKenzie Medical Center
525
mi
from
McKenzie, TN
Click here to add this to my saved trials
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Radiant reserach Inc.
571
mi
from
San Antonio, TX
Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Radiant reserach Inc.
571
mi
from
San Antonio, TX
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Cactus Kids Pediatrics
1007
mi
from
Yuma, AZ
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Cactus Kids Pediatrics
1007
mi
from
Yuma, AZ
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Radiant Reserach
1111
mi
from
Pinellas Park, FL
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Radiant Reserach
1111
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
LSRN Research
618
mi
from
Nashville, TN
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
LSRN Research
618
mi
from
Nashville, TN
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Wee Care Pediatrics
788
mi
from
Layton, UT
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Wee Care Pediatrics
788
mi
from
Layton, UT
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Axis Clinical Trials
1173
mi
from
Los Angeles, CA
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Axis Clinical Trials
1173
mi
from
Los Angeles, CA
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Spence Medical Reserach
682
mi
from
Picayune, MS
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Spence Medical Reserach
682
mi
from
Picayune, MS
Click here to add this to my saved trials
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated:  9/9/2015
Haywood Pediatric
839
mi
from
Clyde, NC
P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Status: Enrolling
Updated: 9/9/2015
Haywood Pediatric
839
mi
from
Clyde, NC
Click here to add this to my saved trials
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: a Randomized Controlled Trial
Status: Enrolling
Updated:  9/10/2015
UCSF Medical Center
1340
mi
from
San Francisco, CA
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: a Randomized Controlled Trial
Status: Enrolling
Updated: 9/10/2015
UCSF Medical Center
1340
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: a Randomized Controlled Trial
Status: Enrolling
Updated:  9/10/2015
University of California, San Francisco Medical Center
1343
mi
from
San Francisco, CA
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: a Randomized Controlled Trial
Status: Enrolling
Updated: 9/10/2015
University of California, San Francisco Medical Center
1343
mi
from
San Francisco, CA
Click here to add this to my saved trials
Probiotics for Girls With Recurring Urinary Tract Infections
H-23187: Probiotic Prophylaxis Against Recurrent Pediatric Urinary Tract Infection
Status: Enrolling
Updated:  9/11/2015
Texas Children's Hospital
572
mi
from
Houston, TX
Probiotics for Girls With Recurring Urinary Tract Infections
H-23187: Probiotic Prophylaxis Against Recurrent Pediatric Urinary Tract Infection
Status: Enrolling
Updated: 9/11/2015
Texas Children's Hospital
572
mi
from
Houston, TX
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated:  9/14/2015
ENT Associates of South Florida
1292
mi
from
Boynton Beach, FL
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated: 9/14/2015
ENT Associates of South Florida
1292
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated:  9/14/2015
Clinical Research Facility
1143
mi
from
Sarasota, FL
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated: 9/14/2015
Clinical Research Facility
1143
mi
from
Sarasota, FL
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated:  9/14/2015
Austin Ear, Nose, and Throat Clinic
515
mi
from
Austin, TX
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated: 9/14/2015
Austin Ear, Nose, and Throat Clinic
515
mi
from
Austin, TX
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated:  9/14/2015
San Antonio Ear, Nose & Throat Research
576
mi
from
San Antonio, TX
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated: 9/14/2015
San Antonio Ear, Nose & Throat Research
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated:  9/14/2015
Ear Institute of Texas
576
mi
from
San Antonio, TX
FST-201 In The Treatment of Acute Fungal Otitis Externa
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension in Subjects With Acute Fungal Otitis Externa
Status: Enrolling
Updated: 9/14/2015
Ear Institute of Texas
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated:  9/14/2015
ENT Associates of South Florida
1292
mi
from
Boynton Beach, FL
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated: 9/14/2015
ENT Associates of South Florida
1292
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated:  9/14/2015
Clinical Research Facility
1143
mi
from
Sarasota, FL
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated: 9/14/2015
Clinical Research Facility
1143
mi
from
Sarasota, FL
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated:  9/14/2015
Austin Ear, Nose, and Throat Clinic
515
mi
from
Austin, TX
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated: 9/14/2015
Austin Ear, Nose, and Throat Clinic
515
mi
from
Austin, TX
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated:  9/14/2015
San Antonio Ear, Nose & Throat Research
576
mi
from
San Antonio, TX
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated: 9/14/2015
San Antonio Ear, Nose & Throat Research
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated:  9/14/2015
Ear Institute of Texas
576
mi
from
San Antonio, TX
FST-201 In The Treatment of Acute Otitis Externa
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status: Enrolling
Updated: 9/14/2015
Ear Institute of Texas
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery
Phase 3 Study of the Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study-INhibition of INcisional INfections)
Status: Enrolling
Updated:  9/15/2015
University of South Alabama Medical Center
740
mi
from
Mobile, AL
Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery
Phase 3 Study of the Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study-INhibition of INcisional INfections)
Status: Enrolling
Updated: 9/15/2015
University of South Alabama Medical Center
740
mi
from
Mobile, AL
Click here to add this to my saved trials